AI assistant
Sending…
Scienture Holdings, Inc. — Director's Dealing 2020
Apr 16, 2020
35013_dirs_2020-04-16_42b64073-672f-4f84-a686-e22890964baf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TRXADE GROUP, INC. (MEDS)
CIK: 0001382574
Period of Report: 2020-04-14
Reporting Person: Patel Prashant (Director, President, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-04-14 | Common stock | A | 50000 | $6.12 | Acquired | 1255000 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common stock | 400000 | Indirect |
| Common stock | 416667 | Indirect |
Footnotes
F1: Shares are fully earned as of April 14, 2020, The table above includes the full amount of such shares which are fully earned by the Reporting Person as of April 14, 2020, even though such shares have not been issued as of the date of this report.
F2: Issued to the Reporting Person as a compensation bonus for 2019. Exempt under Rule 16b-3(d).
More from Scienture Holdings, Inc.
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 22
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 5
Regulatory Filings
2026
May 1
Annual Report
2026
Apr 30
Annual Report
2026
Mar 30
Regulatory Filings
2025
Nov 17
Regulatory Filings
2025
Nov 14
Major Shareholding Notification
2025
Nov 14